Diffuse alveolar hemorrhage following itraconazole injection

Intern Med. 2010;49(5):497-500. doi: 10.2169/internalmedicine.49.2735. Epub 2010 Mar 1.

Abstract

Diffuse alveolar hemorrhage (DAH) syndrome is potentially fatal. We encountered a nearly fatal case of DAH possibly due to intravenous itraconazole (ITCZ). A 53-year-old man with chronic pulmonary aspergillosis underwent pneumonectomy of the left lung 15 days prior to the onset of DAH, which was confirmed by bronchoalveloar lavage. The battery of diagnostic evaluations performed revealed no other positive etiological factor, leading to the diagnosis of DAH possibly induced by intravenous ITCZ with a positive drug lymphocyte stimulation test. The patient did not respond to pulse methylprednisolone therapy, but responded dramatically to direct hemoperfusion using a polymyxin B-immobilized fiber column (PMX) therapy.

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / administration & dosage
  • Antifungal Agents / adverse effects*
  • Antifungal Agents / therapeutic use
  • Chronic Disease
  • Hemoperfusion
  • Hemorrhage / chemically induced*
  • Hemorrhage / therapy
  • Humans
  • Injections, Intravenous
  • Itraconazole / administration & dosage
  • Itraconazole / adverse effects*
  • Itraconazole / therapeutic use
  • Lung Diseases / chemically induced*
  • Lung Diseases / therapy
  • Male
  • Middle Aged
  • Polymyxin B
  • Pulmonary Aspergillosis / drug therapy

Substances

  • Antifungal Agents
  • Itraconazole
  • Polymyxin B